Drugmakers’ powerhouse lobby did not exactly make good on its early August threat to hold Democrats “accountable” this fall after the caucus voted to let the government negotiate drug prices.
The Pharmaceutical Research and Manufacturers of America’s political action committee put $2,000 towards the New Democrat Coalition Action Fund on Aug. 22, just weeks after every member voted for the sweeping Inflation Reduction Act that includes an unprecedented move to let the federal government negotiate the prices of some of the country’s costliest medicines.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
